Pixilab
Home › Companies › Biotechnology › Graph Therapeutics

Graph Therapeutics

precision-immunology techbio

Graph Therapeutics is active in the biotechnology space, founded in 2024.

The company sits in the biotechnology segment, where it competes on its core product or service.

It is recorded at the Pre_Seed stage.

The company reports a headcount in the c_00001_00010 range.

SectorBiotechnology
Founded2024
Employeesc_00001_00010
Stagepre_seed

Website: graphtx.com

Browse related

Emails and contact routes are reserved for registered members.
Create a free account